Week In Review: GenScript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse
May 15, 2021 at 14:39 PM EDT
GenScript raised more than $1 billion from Hillhouse Capital in several different investments, including a $500 million commitment to GenScript's Legend Biotech CAR-T subsidiary. Before the investments, Legend was worth $4 billion.
